Compound Radar

Calumet, Inc. (CLMT) Stock Analysis

Price $53.91
Market cap $4.74B
Next earnings Nov 6, 2026
Entry status Wait

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

35
35/100 Avoid
  • Financial Health 5
  • Profitability 25
  • Business Quality 60
  • Balance Sheet 15
  • Cash Flow 80

Why this rating?

Health 35/100 — Avoid

Strongest Cash Flow 80/100
Softest Financial Health 5/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Calumet, Inc. (CLMT) is a Specialty Chemicals company in the Basic Materials sector. Compound Radar rates Calumet, Inc. 35/100 (Avoid) due to solid business quality, strong revenue growth, and elevated leverage.

Investment profile

  • Quality Moderate
  • Growth Strong
  • Balance Sheet Stretched
  • Valuation Elevated

Financial highlights

Valuation

  • Forward P/E 85.57
  • PEG 0.65
  • EV/Revenue 1.56

Profitability

  • Revenue Growth 40.8%
  • Gross Margin 6.9%
  • Operating Margin -4.6%
  • Net Margin -3.0%

Financial strength

  • Cash $109.80M
  • Debt $2.37B
  • Net Cash $-2.26B
  • Free Cash Flow $56.60M
  • Current Ratio 0.84

Similar companies

Peers in Specialty Chemicals, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Specialty Chemicals →

FAQ

How Compound Radar scores and tracks Calumet, Inc. (CLMT).

View Methodology & FAQ →